Ad is loading...
MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2024 All rights reserved. Tickeron Inc.
SPRO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Spero Therapeutics (SPRO) Earnings Date & Reports

A.I. Advisor
published Earnings

SPRO is expected to report earnings to rise 21.87% to -38 cents per share on March 13

Spero Therapeutics SPRO Stock Earnings Reports
Q4'24
Est.
$-0.39
Q3'24
Beat
by $0.18
Q2'24
Beat
by $0.05
Q1'24
Missed
by $0.12
Q4'23
Beat
by $1.02
The last earnings report on November 14 showed earnings per share of -31 cents, beating the estimate of -50 cents. With 465.37K shares outstanding, the current market capitalization sits at 63.78M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
SPRO
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View Trends For SPRO
(Try 14 days for Free)
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of novel therapies for the treatment of resistant bacterial infections

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
675 Massachusetts Avenue
Phone
+1 857 242-1600
Employees
46
Web
https://www.sperotherapeutics.com